Journavx fills a critical gap between over-the-counter pain medicines (e.g., aspirin and ibuprofen), which offer only modest relief, and opioids, which are effective but come with serious side effects.
Eli Lilly and Company enhances digital healthcare offerings to address delays in diagnosis and treatment.
CRN expressed concern over reports of misusing high-dose vitamin A, particularly for children. Excessive intake of preformed vitamin A can lead to toxicity.
“We aren’t just reducing bureaucratic sprawl. We are realigning the organization with its core mission and our new priorities in reversing the chronic disease epidemic,” HHS Secretary Robert F. Kennedy Jr. said.
The Senate confirmed Dr. Makary's nomination by a vote of 56-44.
The Senate Finance Committee voted 14 -13 along party lines to advance Oz’s nomination to the full Senate for a vote.
The company began building a foundation for automation and AI and in 2021, the company formed an AI Center of Excellence to identify promising use cases for the application of AI technologies, and to test whether potential solutions deliver anticipated results.
OLLIE integrates with Pleio’s GoodStart program and supports pharmaceutical companies in earlier identification and understanding of patient sentiment and confidence.
"Board of Directors Dinner” on Tuesday, April 29 will feature a tribute to Jim’s legacy of industry dedication and relationship-building.
Rosacea Treatment Algorithms are intended to provide a comprehensive summary of therapeutic options for each phenotype of the disease.
If confirmed by the Senate, Monarez will be the first nonphysician to lead the agency in more than 50 years.
A recent analysis shows pharmacists play a crucial role in reducing ADE incidents through proactive medication management and patient education.
A new publication suggests that decision makers take both a product lifetime view and a broader societal perspective when judging and rewarding value creation.
The Wegovy savings offer is good for all dose strengths of Wegovy.
The report found that digital tools play an important role in enhancing the patient experience but patients and pharmacy teams also value personal interactions.
Despite the decrease, the landscape of pharmaceutical transformation still remains vibrant.
